Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.
about
Gut microbiota and metabolic syndromeLactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injuryNonalcoholic fatty liver disease as a multi-systemic diseaseGut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of MetabolomicsNutrition and Physical Activity in Nonalcoholic Fatty Liver DiseaseEndocrine causes of nonalcoholic fatty liver diseaseDietary habits and behaviors associated with nonalcoholic fatty liver diseaseThe role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver diseaseContributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancerPromising therapies for treatment of nonalcoholic steatohepatitis.Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis.Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.Mechanisms of Liver Injury in Non-Alcoholic SteatohepatitisCausative role of gut microbiota in non-alcoholic fatty liver disease pathogenesisRecent advances in the development of farnesoid X receptor agonistsPediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets.Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters.Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity.Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.Effect of Lactobacillus plantarum Strain K21 on High-Fat Diet-Fed Obese Mice.Efficacy of probiotics in non-alcoholic fatty liver disease in adult and children: A meta-analysis of randomized controlled trials.Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.Phylogenetic identification of bacterial MazF toxin protein motifs among probiotic strains and foodborne pathogens and potential implications of engineered probiotic intervention in food.The Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical TrialProbiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidencesGut microbiota and clinical disease: obesity and nonalcoholic Fatty liver disease.Hepatic function and the cardiometabolic syndrome.Clinical efficacy and mechanism of probiotics in allergic diseases.Clinical approaches to non-alcoholic fatty liver diseaseDo symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial.Bifidobacterium breve with α-linolenic acid alters the composition, distribution and transcription factor activity associated with metabolism and absorption of fat.Probiotics and Nonalcoholic Fatty liver Disease.Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments.Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets.Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools.Potent effects of dioscin against obesity in micePaediatric non-alcoholic fatty liver disease: an overview.
P2860
Q24563886-A2E73E1F-17B4-47CD-8D00-801E530C29DBQ24629732-7C3D9BD6-4177-4288-BD61-6D48BB1D77D9Q26749290-119A69B7-F053-4496-88A0-4B0339258930Q26753047-8F44FA6B-798A-4CD0-AD05-0CF5456EF555Q26771752-E14D5C51-B11F-4F5C-BBC7-4FF23AFC28BFQ26780254-ECFC1F6F-6452-47DE-A4B4-1831D42126BEQ26830594-3FA708F2-C3F8-4105-A0B2-20394896F5EEQ26852498-1B1F41A6-7191-405B-B63C-607631045A8CQ26992106-DC9F89CE-FE5B-44D3-8BD6-897CBFD4D806Q30248578-F3296DE8-8D9B-4712-AED7-F677826CEAC2Q30377409-04E4DBC3-B2F1-4B01-8DEB-83984B6BA3E4Q33714116-9FA8E63C-16F3-4704-BAFC-44CBC87AE87FQ33898945-50FD8CA2-4D17-4BBA-A6D4-8FA566D395C7Q34462482-E30CCD6B-4930-4D36-81F7-FDDCDC91E508Q34464043-1102254E-A49F-4A92-8186-6BEBD8EC63EDQ34636684-F641FBCF-FE2D-403F-BBB5-16F8B79EF787Q34641213-A5BD35D7-B67E-4765-88C2-7FC49242982CQ34648009-73F2135D-F8D0-4B93-A607-F97847E69C00Q34915414-BF5C9A4A-684A-436F-8C06-D66F8B948069Q35127037-D6FAC226-3394-4585-8155-AE0DF2DC04E1Q35158545-19D5F5C3-E3D4-4918-8882-ED839EDF4025Q35920786-9DE5743D-D47F-4DB6-8C6D-8C1550B10898Q35998233-CC56B811-0835-49B7-AEC5-D58236A71A50Q36167936-57665204-327F-4DD0-800A-C2F709FA7B14Q36459875-AAACD3AF-12BE-4529-9E28-C52D377934E3Q36732958-8374C1D4-0DA1-4B1B-913F-B9CFFFEC3CCBQ37034650-046FF2D0-6D25-4ABB-A7C1-0323EEBE0683Q37101501-2F62EC22-DEC5-4403-8347-F76A02A7ED06Q37232122-8577AFCA-B26F-4BDD-9518-87A35FF5621DQ37285699-BD126FC9-A7FC-4354-B90A-406EBBD060BCQ37596187-E4FED68B-930C-46B3-A608-E8D9E3F1BCEBQ37661610-B4DDFF3F-6B76-4252-A7FA-8A5009F5A41EQ37683805-3F4235B4-0520-404E-B6DD-4108621644D9Q37708418-5BF3C1A6-69D2-4A93-A941-2239E2BB2DEFQ37926944-80FC023A-2E0B-45AC-B59F-DF9B1083B066Q38121574-18B11C4B-BD40-44D7-9B14-59D44B872BBDQ38160948-EE995F73-EF9E-400F-8515-C237A90F031AQ38209324-7FB0E7B7-718A-453C-A43F-46E56543A876Q38301574-3A02AE6D-9832-4866-BC31-BB5F26C05682Q38370919-CB4ED4E8-05C2-47F4-8C97-C9D31903E669
P2860
Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Probiotics as an emerging ther ...... ar and biochemical mechanisms.
@en
Probiotics as an emerging ther ...... ar and biochemical mechanisms.
@nl
type
label
Probiotics as an emerging ther ...... ar and biochemical mechanisms.
@en
Probiotics as an emerging ther ...... ar and biochemical mechanisms.
@nl
prefLabel
Probiotics as an emerging ther ...... ar and biochemical mechanisms.
@en
Probiotics as an emerging ther ...... ar and biochemical mechanisms.
@nl
P2093
P1476
Probiotics as an emerging ther ...... lar and biochemical mechanisms
@en
P2093
Anna Iacono
Giuseppina Mattace Raso
Roberto Berni Canani
P304
P356
10.1016/J.JNUTBIO.2010.10.002
P577
2011-02-02T00:00:00Z